Latest Breaking News On - Pamelap palmer - Page 1 : vimarsana.com

AcelRx Receives IDE Approval for Niyad and Advances to a Single Registration Study

/PRNewswire/ AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), (AcelRx), a specialty pharmaceutical company focused on the development and commercialization of.

United statesVince angottiPamelap palmerAcelrx pharmaceuticals incDrug administrationInvestigational device exemptionAcelrx pharmaceuticalsUnited states foodChief executive officerChief medical officerBreakthrough device designationEmergency use authorizationBreakthrough device designation status

AcelRx Pharma (ACRX) Receives IDE Approval for Niyad and Advances to a Single Registration Study

AcelRx Pharma (ACRX) Receives IDE Approval for Niyad and Advances to a Single Registration Study
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesVince angottiPamelap palmerAcelrx pharmaceuticals incDrug administrationAcelrx pharmaceuticalsInvestigational device exemptionUnited states foodChief executive officerChief medical officerBreakthrough device designationEmergency use authorization